Literature DB >> 23736890

Regulating surgical oncotaxis to improve the outcomes in cancer patients.

Toshihiro Hirai1, Hideo Matsumoto, Hisako Kubota, Yoshiyuki Yamaguchi.   

Abstract

Excessive surgical stress and postoperative complications cause a storm of perioperative cytokine release, which has been shown to enhance tumor metastasis in experimental models. We have named this phenomenon "surgical oncotaxis". The mechanisms that underpin this process are thought to be excessive corticosteroid secretion, coagulopathy in the peripheral vasculature, immune suppression and excessive production of reactive oxygen species. Nuclear factor-kappa B (NFkB) activation plays a key role in these mechanisms. Minimally invasive surgical techniques should be used, and postoperative complications should be avoided whenever possible to lessen the impact of surgical oncotaxis. Furthermore, there may be a role for a small preoperative dose of corticosteroid or the use of free radical scavengers in the perioperative period. Recently, there has been a great deal of interest in omega-3 fatty acid, because it regulates NFkB activation. The use of multimodal treatments that regulate surgical oncotaxis may be as important as chemotherapy for determining the outcome of patients with cancer undergoing surgery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23736890     DOI: 10.1007/s00595-013-0627-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  77 in total

Review 1.  Perioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma.

Authors:  Antônio Marcos Raimondi; Hélio Penna Guimarães; José Luiz Gomes do Amaral; Patrícia Helena Rocha Leal
Journal:  Sao Paulo Med J       Date:  2006-03-02       Impact factor: 1.044

2.  Inhibitory effects of immunopotentiators on the enhancement of lung metastases induced by operative stress in rats.

Authors:  T Hattori; Y Hamai; T Ikeda; W Takiyama; T Harai; Y Miyoshi
Journal:  Gan       Date:  1982-02

3.  Enhancing effect of thoracotomy on tumor growth in rats with special reference to the duration and timing of the operation.

Authors:  T Hattori; Y Hamai; W Takiyama; T Hirai; T Ikeda
Journal:  Gan       Date:  1980-06

Review 4.  Venous thromboembolism and cancer.

Authors:  A K Kakkar; F de Lorenzo; G F Pineo; R C Williamson
Journal:  Baillieres Clin Haematol       Date:  1998-09

5.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

6.  Neoadjuvant interferon alfa-2b treatment in a murine model for metastatic ocular melanoma: a preliminary study.

Authors:  S Dithmar; D Rusciano; M J Lynn; D H Lawson; C A Armstrong; H E Grossniklaus
Journal:  Arch Ophthalmol       Date:  2000-08

7.  Use of dabigatran etexilate to reduce breast cancer progression.

Authors:  Karen DeFeo; Candace Hayes; Michael Chernick; Joanne Van Ryn; Susan K Gilmour
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

8.  Interleukin-6 stimulates coagulation, not fibrinolysis, in humans.

Authors:  J M Stouthard; M Levi; C E Hack; C H Veenhof; H A Romijn; H P Sauerwein; T van der Poll
Journal:  Thromb Haemost       Date:  1996-11       Impact factor: 5.249

9.  Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach.

Authors:  M Sierzega; P Kolodziejczyk; J Kulig
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

10.  TLR-4 signalling accelerates colon cancer cell adhesion via NF-κB mediated transcriptional up-regulation of Nox-1.

Authors:  D Peter O'Leary; Lavinia Bhatt; John F Woolley; David R Gough; Jiang H Wang; Thomas G Cotter; H Paul Redmond
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more
  7 in total

1.  Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.

Authors:  Gina L Razidlo; Christopher Magnine; Arthur C Sletten; Rachel M Hurley; Luciana L Almada; Martin E Fernandez-Zapico; Baoan Ji; Mark A McNiven
Journal:  Cancer Res       Date:  2015-05-14       Impact factor: 12.701

2.  Low invasiveness of thoracoscopic esophagectomy in the prone position for esophageal cancer: a propensity score-matched comparison of operative approaches between thoracoscopic and open esophagectomy.

Authors:  Shinsuke Kanekiyo; Shigeru Takeda; Masahito Tsutsui; Mitsuo Nishiyama; Masahiro Kitahara; Yoshitaro Shindo; Yukio Tokumitsu; Shinobu Tomochika; Yoshihiro Tokuhisa; Michihisa Iida; Kazuhiko Sakamoto; Nobuaki Suzuki; Shigeru Yamamoto; Shigefumi Yoshino; Shoichi Hazama; Tomio Ueno; Hiroaki Nagano
Journal:  Surg Endosc       Date:  2017-10-26       Impact factor: 4.584

3.  Prognostic factors for gastrectomy in elderly patients with gastric cancer.

Authors:  Daisuke Ueno; Hideo Matsumoto; Hisako Kubota; Masaharu Higashida; Takashi Akiyama; Akiko Shiotani; Toshihiro Hirai
Journal:  World J Surg Oncol       Date:  2017-03-11       Impact factor: 2.754

4.  Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.

Authors:  Juan Garona; Natasha T Sobol; Marina Pifano; Valeria I Segatori; Daniel E Gomez; Giselle V Ripoll; Daniel F Alonso
Journal:  Cancer Res Treat       Date:  2018-06-01       Impact factor: 4.679

5.  Perioperative safety and short-term efficacy of functional minimally invasive esophagectomy.

Authors:  Huibing Liu; Defeng Jin; Qian Wang; Zhaoqing Cui; Luchang Zhang; Yutao Wei
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  CXCR2 expression and postoperative complications affect long-term survival in patients with esophageal cancer.

Authors:  Tomohiko Nishi; Hiroya Takeuchi; Sachiko Matsuda; Masaharu Ogura; Hirofumi Kawakubo; Kazumasa Fukuda; Rieko Nakamura; Tsunehiro Takahashi; Norihito Wada; Yoshiro Saikawa; Tai Omori; Yuko Kitagawa
Journal:  World J Surg Oncol       Date:  2015-08-01       Impact factor: 2.754

7.  Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization.

Authors:  Maria F Gottardo; Carla S Capobianco; Johanna E Sidabra; Juan Garona; Yasser Perera; Silvio E Perea; Daniel F Alonso; Hernan G Farina
Journal:  Sci Rep       Date:  2020-09-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.